Related Experiment Video
Updated: May 9, 2026
07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Colorectal cancer defeating? Challenge accepted!
S Di Franco1, M Todaro1, F Dieli2
1Department of Surgical and Oncological Sciences, University of Palermo, Via Liborio Giuffre' 5, 90127 Palermo, Italy.
Molecular Aspects of Medicine
|August 10, 2013
Summary
Colorectal cancer stem cells (CCSCs) drive tumor growth and metastasis. Understanding their regulation offers potential for new, targeted colorectal cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Cancer Stem Cell Research
Background:
- Colorectal tumors exhibit cellular heterogeneity with varying differentiation stages.
- Colorectal cancer stem cells (CCSCs) possess self-renewal and multi-lineage differentiation capabilities, similar to healthy stem cells.
- The tumor microenvironment significantly influences CCSC stemness, differentiation, and epithelial-mesenchymal transition, promoting metastasis.
Purpose of the Study:
- To explore the role of colorectal cancer stem cells (CCSCs) in colorectal tumor progression.
- To investigate the factors influencing CCSC fate and behavior within the tumor microenvironment.
- To highlight the potential of targeting CCSCs for novel colorectal cancer treatments.
Main Methods:
- Review of current literature on colorectal cancer stem cells.
- Analysis of cellular and molecular mechanisms regulating CCSC properties.
- Discussion of tumor heterogeneity and immune response in relation to therapeutic resistance.
Main Results:
- CCSCs are implicated in tumor dissemination and the formation of metastatic lesions.
- Tumor cell heterogeneity and immune resistance contribute to conventional therapy failure.
- Understanding CCSC regulation is crucial for developing effective treatments.
Conclusions:
- Targeting colorectal cancer stem cells (CCSCs) holds promise for improving patient survival.
- Further research into CCSC quiescence, cell cycle, self-renewal, and resistance mechanisms is vital.
- Tailor-made therapies based on CCSC biology could significantly impact colorectal cancer morbidity and mortality.
Keywords:
Cancer stem cellColorectal cancerImmune systemIndividualized therapyTargetingTumour microenvironmentMore Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...